yl6809ÓÀÀû

ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

ÄÐÐÔµÄ׳´ó £¬ÔÚÓÚ´ÓÈÝ¡ª¡ª¡ªÏ²±¨£¡¹úÄÚÊ׸ö£¡Î÷°àÑÀÔ­Ñнø¿ÚèÛéÚËáÎ÷µØÄǷǿڷþ»ìÐüÒº»ñÅúÉÏÊУ¡

ÈÕÆÚ£º

2026Äê04ÔÂ03ÈÕ 14:35


9f73dc79-48e8-48fd-95ab-d40c4eca751a

èÛéÚËáÎ÷µØÄǷǿڷþ»ìÐüÒº£¨ÐÒ·ö½¡®£©ÉÏÊÐÉêÇëÕýʽ»ñÅú¡£×÷Ϊ¹úÄÚÊ׸ö¿Ú·þ»ìÐüÒº¼ÁÐ͵ÄÎ÷µØÄÇ·Ç £¬Õâ¿îÓÉÎ÷°àÑÀÔ­Ñгö²úµÄ²úÆ· £¬²»½öÌí²¹ÁËED£¨²ªÆðÖ°ÄÜ×è°­£©Ò½ÖÎÁìÓòµÄ¼ÁÐÍ¿Õȱ £¬¸ü±ê־ȡÄÐÐÔ½¡È«ÖÎÀíÂõÈëÁ˾«×¼¿ØÁ¿¡¢ÂÄÀúÓÅÏȵÄн׶Ρ£Ëü¼È·ÇȫгɷÖ £¬Ò²·ÇÊ×·Â £¬¶øÊÇÖ±»÷»¼Õßδ±»Âú×ãµÄÓÃÒ©ÐèÒª £¬ÒԸĽøÐÍÐÂÒ©µÄ×ËÊÆ £¬³Áнç˵·þÒ©ÂÄÀú——¸üÓÐЧ £¬¸üÃæ×Ó £¬¸ü´ÓÈÝ¡£

 

Ò»¡¢Êг¡½ü¿ö£ºEDÒ½ÖÎÐèÒªÏÔÖø £¬´«Í³ÓÃÒ©Í´µãÈÔ´æ

 

ÏÖ½×¶Î,EDÒѳÉΪӰÏìÄÐÐÔÉúÑÄÖÊÁ¿µÄ³ÁÒªÎÊÌâÖ®Ò»¡£ÔÚÎÒ¹úÓÐ×ÅÖØ´óµÄ»¼Õß»ùÊý¡£¾Ý¹«¿ªÊý¾ÝÏÔʾ £¬ÎÒ¹úED»¼ÕßÈËÊýÔ¼1.4ÒÚÈË¡£¾Ý¡¶2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé¡·ÏÔʾ £¬31-40ËêÄÐÐÔÕ¼±È44.79% £¬21-30ËêȺÌåÒ²´ïµ½38.03% £¬³öÏÖÄêÇữÇ÷Ïò¡£

´ÓÊг¡¹æÄ£À´¿´ £¬EDÒ©ÎïÈü·ÌåÁ¿¿É¹Û £¬¶øÎ÷µØÄÇ·ÇÔÚËùÓÐEDÀàÒ©ÎïÊг¡Õ¼±È¶ÀÙÆ°ÁÍ· £¬2024ÄêÕ¼±È¸ß´ï71.96%¡£×÷ΪPDE5ÒÖÔì¼ÁµÄÖ÷ÌâÆ·Àà £¬Î÷µØÄǷǸüÊDZ»¹úÄÚ±í¶àÏîȨÍþÖ¸ÄÏ£¨Èç¡¶²ªÆðÖ°ÄÜ×è°­Õï¶ÏÓëÒ½ÖÎÖ¸ÄÏ¡·¡¶Å·ÖÞÃÚÄòѧ»áÐÔÓëÉúÖ³½¡È«Ö¸ÄÏ¡·µÈ£©ÁÐΪEDÒ½ÖεÄÊ×ѡҩÎï £¬ÆäÓÐЧÐÔÓ밲ȫÐÔÒѵõ½¿í·ºÑéÖ¤¡£

Ö»¹Ü¿Ú·þPDE5ÒÖÔì¼ÁÊÇEDÒ½ÖεÄÖ÷Á÷Ñ¡Ôñ £¬ÇÒ38.64%µÄÄÐÐÔÔø·þÓùý¿¹EDÒ©Îï1 £¬µ«´«Í³Æ¬¼ÁµÄÍ´µãʼÖÕÄÑÒÔ½â¾ö £¬³ÉΪ»¼ÕßÓÃÒ©µÄÒþÐÎÃż÷£º

¼ÁÁ¿¹Ì¶¨£ºÏÖÓе¥ºÐ°ü×°¼ÁÐͼÁÁ¿¾ùÒѹ̶¨ £¬ÎÞ·¨Æ¥Åä¸ö±ð»¯ÐèÒª £»

ÐèË®ËÍ·þ£ºÎÞ·¨Âú×ãÎÞˮǰÌáÏÂËæÊ±ËæµØÔ½·¢±ã½Ý¸øÒ© £»

ÒþÖÔÀDZ·£ºÒ©Æ¬°ü×°Ò×¶³öÒþÖÔ £¬ÓÈÆäÔÚÉç½»³¡¾°ÏÂÓÃÒ©·½±ãÐÔ´ó·ù½µÂä £»

ÍÌÑÊ×è°­£ºÔ¼40.2£¥µÄÄÐÐÔ´æÔÚÍÌÑÊÄÑÌâ2 £¬Æ¬¼ÁÄÑÒÔÂú×ãÍÌÑÊ×è°­ÕßÓÃÒ©ÐèÒª¡£

 

¶þ¡¢ÐÒ·ö½¡®£ºÒԸĽøÊµÏÖÂÄÀúÉý¼¶¾«×¼»÷ÖÐÁÙ´²Í´µã

 

ÐÒ·ö½¡®µÄÉÏÊÐ £¬ÕýÊǶÔÕâËÄ´óÍ´µãµÄ¾«×¼»ØÓ¦£º 

¾«×¼¼ÁÁ¿¶¨Ô죺¼ÁÁ¿¿Éƾ¾ÝÐèÒª½Ã½Ýµ÷½Ú £¬25-100mg×ÔÓɵ÷Õû £¬Æ¥Åä¸öÐÔ»¯ÐèÒª £»

ʹÓ÷½±ã¿ì½Ý£ºÎ¢·Û»¯·Öɢϵͳ £¬ÎÞÐèË®ËÍ·þ £¬ËæÊ±ËæµØÊµÏÖ¸øÒ© £¬ÊÊÅä¶àÔªÉúÑij¡¾° £»

È«ÐÂÓÃÒ©ÂÄÀú£º°Ñ“͵͵ÃþÃþÍÌÆ¬”Éý¼¶Îª“Õý´ó¹âÃ÷¿ÚÅç¸øÒ©” £¬½â¾öÉç½»³¡¾°µÄÒþÖÔÀDZ·¡£

ºÏÓÃÈËȺ¿í·º£º³ö¸ñÊʺÏÍÌÑÊÄÑÌâ¡¢Ð辫ȷ¼ÁÁ¿µ÷ÕûµÄʹÓÃÕß

 

Èý¡¢´Ó“ÓÐЧ”µ½“ºÃÓÔ£ºÒ»³¡¹ØÓÚ·þÒ©ÂÄÀúµÄÀíÏë¸ïÃü

 

ÐÒ·ö½¡®µÄ»ñÅú £¬Ô¶·ÇÒ»´Îµ¥Ò»µÄ¼ÁÐ͸Ľø £¬¶øÊÇÒ»³¡¹ØÓÚEDÒ½ÖεÄÀíÏë¸ïÃü——ÎÒÃÇÔÚ³Áнç˵ʲô²ÅÊÇ“ºÃÒ©”¡£

ÓÆ¾ÃÒÔÀ´ £¬Ò½Ò©ÐÐÒµÖ´×»þ¾áêÓªÒ©ÎïµÄ“ÓÐЧÐÔ” £¬È´ÍùÍùºöÂÔÁË“¿ÉÓÃÐÔ”¡£µ±»¼Õß±ØÒªêþҩƬ¡¢ÕÒË®±­¡¢ÍÆË㹦·ò¡¢¶ã±ÜÑÛ¹âʱ £¬Ò©ÎïµÄÁÆÐ§ÒÑÔÚ²ã²ãÕÛËðÖдòÁËÕÛ¿Û¡£

ÐÒ·ö½¡®µÄ³öÏÖ £¬±ê־ȡEDÒ½ÖÎÕýʽ´Ó“·þÒ©Öβ¡”µÄ1.0ʱÆÚ £¬ÂõÈë“ÂÄÀúÓÅÏÈ”µÄ2.0ʱÆÚ¡£Õâ²»½öÊǼ¼ÊõµÄ½øÈ¡ £¬¸üÊǼÛÖµ¹ÛµÄת±ä£º

  • ´Ó“»¼ÕßÊÊÓ¦Ò©Î½“Ò©ÎïÊÊÓ¦»¼Õß”

  • ´Ó“µ¥Ò»¼ÁÁ¿”µ½“¸öÐÔ»¯¹æ»®”

  • ´Ó“Ò½ÁƳ¡¾°”µ½“ÉúÑij¡¾°”

  • ´Ó“Öβ¡”µ½“ÖÎÐÄ”

“¸úÓÐÁµÈË×ö»¶ÀÖÊ £¬±ðÎÊÊǽÙÊÇÔµ¡£”Õâ¾äÀ´×Ô¡¶Á÷¹âÆ®¶¯¡·µÄ¸è´Ê £¬Â·¾¡ÁËÈ˼äÇé°®µÄ´¿ÕýÓëÈ÷ÍÑ¡£¶øÒ»·Ý´ÓÈÝµÄµ×Æø £¬ÕýÊÇÕâ“»¶ÀÖÊ”×îºÃµÄÆðÍ·¡£

´Ë¿Ì £¬ÐÒ·ö½¡® ÔÚÒ½Ò©ÁìÓòÕÒµ½ÁËеÄ×¢½Å——ÕæÕýµÄÒ½ÖÎ £¬¸Ãµ±Èû¼ÕßÔÚ×êÓª½¡È«µÄ··ÉÏ £¬±£ÓÐÓ¦ÓеĴÓÈÝÓëÃæ×Ó¡£

ÎÒÃǵȴýÓë¸÷½çЯÊÖ £¬ÈÃÕⳡʼÓÚ¼ÁÐ͵ÄˢР£¬×îÖÕÒý·¢Õû¸öÐÐÒµ¶Ô»¼ÕßÂÄÀúµÄ³ÁйØ×¢¡£ÓÉÓÚ £¬×îºÃµÄÒ© £¬²»½öÊÇÄÜÈò¡ÈËȬÓúµÄÒ© £¬¸üÊÇÈò¡ÈËÔ¸Òâ¶ÔÖÅ·þÓõÄÒ©¡£

×ÊÁÏÆðÔ´

1¡¢2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé

2¡¢Pharmacokinetic Parameters of a Novel SildenafiOral Liquid Suspension Administered to HealthyAdult Men Under Fasted Conditions

3¡¢ÖйúÌØ¶¨ÈËȺÍÌÑÊÖ°ÄÜ×è°­µÄÊ¢Ðв¡Ñ§µ÷²é»ã±¨.ÖлªÎïÀíҽѧÓ뿵¸´ÔÓÖ¾2017Äê12ÔµÚ39¾íµÚ12ÆÚ

4¡¢Ã×ÄÚÍøÊý¾Ý¿â¡¢²úÆ·ÁÙ´²×êÑÐÊý¾Ý

ÓйØÍƼö

¡¾ÍøÕ¾µØÍ¼¡¿